19/11/2013 - 16:45
Two doses of the once-daily, oral factor Xa inhibitor edoxaban were noninferior to warfarin in preventing stroke or systemic embolism in patients with atrial fibrillation in the phase III ENGAGE...
Field of Interest: Cardiology
Categories:
News Feed: Internal Medicine News - Cardiology